(Q27075961)

RAF265 (English)

19 October 2016

C₂₄H₁₆F₆N₆O

1 reference

RAF265 (English)

19 October 2016

CN1C2=C(C=C(C=C2)OC3=CC(=NC=C3)C4=NC=C(N4)C(F)(F)F)N=C1NC5=CC=C(C=C5)C(F)(F)F

1 reference

RAF265 (English)

physically interacts with

19 October 2016

Kinase insert domain receptor

subject has role

reaction inhibitor

1 reference

stated in

Open Targets Platform

https://platform.opentargets.org/drug/CHEMBL558752

14 August 2023

reference URL

Identifiers

InChI

InChI=1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34)

1 reference

RAF265 (English)

19 October 2016

2 references

RAF265 (English)

19 October 2016

ChEBI release 2020-09-01

1 reference

1-Methyl-5-({2-[4-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl}oxy)-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine (English)

19 October 2016

2 references

RAF265 (English)

19 October 2016

ChEBI ID

91451

mapping relation type

2 references

1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-2-benzimidazolamine (English)

19 October 2016

International Chemical Identifier

InChI

InChI=1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34)

1 reference

CHIR-265 (English)

19 October 2016

2 references

inferred from InChIKey

1 reference

1 reference

Guide to Pharmacology Ligand ID

5674

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

5674

CHIR-265 (English)

19 October 2016

1 reference

UNII

8O434L3768

1 reference

0 references

0 references

1 reference

5CT7 (English)